Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Payables (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Payables for 6 consecutive years, with $7.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Payables rose 37.79% year-over-year to $7.3 million, compared with a TTM value of $7.3 million through Dec 2025, up 37.79%, and an annual FY2025 reading of $7.3 million, up 37.79% over the prior year.
  • Payables was $7.3 million for Q4 2025 at Viemed Healthcare, down from $8.7 million in the prior quarter.
  • Across five years, Payables topped out at $8.7 million in Q3 2025 and bottomed at $2.5 million in Q2 2021.
  • Average Payables over 5 years is $5.2 million, with a median of $5.0 million recorded in 2021.
  • The sharpest move saw Payables crashed 60.28% in 2021, then skyrocketed 66.59% in 2023.
  • Year by year, Payables stood at $3.2 million in 2021, then dropped by 18.18% to $2.6 million in 2022, then surged by 57.74% to $4.2 million in 2023, then rose by 27.32% to $5.3 million in 2024, then surged by 37.79% to $7.3 million in 2025.
  • Business Quant data shows Payables for VMD at $7.3 million in Q4 2025, $8.7 million in Q3 2025, and $8.3 million in Q2 2025.